LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
59 hedge funds and large institutions have $133M invested in LogicBio Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
59
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$15.3M | |
| 2 | +$6.86M | |
| 3 | +$5.91M | |
| 4 |
SC
Samlyn Capital
New York
|
+$4.91M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.81M |
Top Sellers
| 1 | -$327K | |
| 2 | -$308K | |
| 3 | -$250K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$163K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$77.3K |